EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Substituted bipyridine-based compounds: Synthesis, enzyme inhibition, anticancer activities and molecular docking studies

Adnan Cetin, Fikret Türkan, Ercan Oğuz, Przemysław Rozbicki, Ewa Wolińska, Danuta Branowska

Letters in Drug Design & Discovery · 2025-11 · 22 (11) · 100269

DOI: 10.1016/j.lddd.2025.100269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2025-11. Verfasst von Adnan Cetin und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yüzüncü Yil Üniversitesi, Bilimsel Araştırma Projeleri Birimi, İstanbul Teknik Üniversitesi.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Yüzüncü Yil Üniversitesi
  • Bilimsel Araştırma Projeleri Birimi, İstanbul Teknik Üniversitesi

Zitieren

APA

Cetin, A., Türkan, F., Oğuz, E., Rozbicki, P., Wolińska, E., & Branowska, D. (2025). Substituted bipyridine-based compounds: Synthesis, enzyme inhibition, anticancer activities and molecular docking studies. Letters in Drug Design & Discovery, 22(11), 100269. https://doi.org/10.1016/j.lddd.2025.100269

Vancouver

Cetin A, Türkan F, Oğuz E, Rozbicki P, Wolińska E, Branowska D. Substituted bipyridine-based compounds: Synthesis, enzyme inhibition, anticancer activities and molecular docking studies. Letters in Drug Design & Discovery. 2025;22(11):100269. doi:10.1016/j.lddd.2025.100269

BibTeX
@article{Cetin2025,
  author = {Cetin, Adnan and Türkan, Fikret and Oğuz, Ercan and Rozbicki, Przemysław and Wolińska, Ewa and Branowska, Danuta},
  title = {Substituted bipyridine-based compounds: Synthesis, enzyme inhibition, anticancer activities and molecular docking studies},
  journal = {Letters in Drug Design & Discovery},
  year = {2025},
  volume = {22},
  number = {11},
  pages = {100269},
  doi = {10.1016/j.lddd.2025.100269}
}
Kostenlos starten →